Skip to main content

Table 1 Metadata and other characteristics of included studies

From: Economic evaluation of implementation science outcomes in low- and middle-income countries: a scoping review

Characteristic

n/N (%)

References

Region of origin of first author (place of work)

 Africa

0 (0%)

–

 Asia

0 (0%)

–

 Europe, North America, Australia

22 (96%)

[13, 17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37]

 Latin America

1 (4%)

[16]

Region of origin of senior author (place of work)

 Africa

0 (0%)

–

 Asia

0 (0%)

–

 Europe, North America, Australia

22 (96%)

[13, 17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37]

 Latin America

1 (4%)

[16]

Region of research (for empirical or case studies only)

 Africa

2 (22%)

[17, 22]

 Asia

1 (11%)

[22]

 Europe, North America, Australia

6 (67%)

[13, 18,19,20,21,22]

 Latin America

0 (0%)

-

 Global

2 (22%)

[16, 23]

Disease/focus area

 Mental health

5 (22%)

[13, 19, 28,29,30]

 Diabetes

2 (9%)

[20, 21]

 HIV/AIDS

3 (13%)

[17, 25, 26]

 Tuberculosis

3 (13%)

[22, 24, 27]

 Universally applicablea

9 (39%)

[16, 23, 31,32,33,34,35,36,37]

 All otherb

3 (13%)

[18, 29, 36]

Publication date

 2020 and 2021

12 (52%)

[17, 18, 22,23,24,25, 27,28,29,30,31,32]

 2016 to 2019

8 (35%)

[16, 19, 21, 26, 33,34,35,36]

 2011 to 2015

3 (13%)

[13, 20, 37]

Study design

 Review

7 (30%)

[25, 30,31,32,33,34,35]

 Methodology

9 (39%)

[16, 20, 23,24,25, 28, 29, 36, 37]

 Empirical research

9 (39%)

[13, 16,17,18,19,20,21,22,23]

 All other

2 (9%)

[26, 27]

Economic perspective

 Healthcare system (provider)

10 (43%)

[13, 16,17,18,19, 21,22,23,24, 29]

 Patient

0 (0%)

–

 Societal

12 (52%)

[20, 25, 27, 28, 30,31,32,33,34,35,36,37]

 Not described/not applicable

1 (4%)

[26]

Linkage to implementation science or costing frameworkc

 Yes

13 (57%)

[13, 16, 20, 23,24,25,26,27,28, 31,32,33, 35]

 No

10 (43%)

[17,18,19, 21, 22, 29, 30, 34, 36, 37]

  1. aThe methods discussed are not being applied to a specific disease
  2. bIncludes stroke, heart disease, and one purely theoretical paper
  3. cThe papers explicitly mention the use of a costing or implementation framework
Back to article page

Implementation Science

ISSN: 1748-5908